Title
Increased iron uptake in the bladder wall of racemose cysts of Taenia solium
Date Issued
01 September 2022
Access level
open access
Resource Type
journal article
Publisher(s)
Elsevier B.V.
Abstract
Racemose neurocysticercosis is an aggressive infection caused by the aberrant expansion and proliferation of the bladder wall of the Taenia solium cyst within the subarachnoid spaces of the human brain. The parasite develops and proliferates in a microenvironment with low concentrations of growth factors and micronutrients compared to serum. Iron is important for essential biological processes, but its requirement for racemose cyst viability and proliferation has not been studied. The presence of iron in the bladder wall of racemose and normal univesicular T. solium cysts was determined using Prussian blue staining. Iron deposits were readily detected in the bladder wall of racemose cysts but were not detectable in the bladder wall of univesicular cysts. Consistent with this finding, the genes for two iron-binding proteins (ferritin and melanotransferrin) and ribonucleotide reductase were markedly overexpressed in the racemose cyst compared to univesicular cysts. The presence of iron in the bladder wall of racemose cysts may be due to its increased metabolic rate due to proliferation.
Volume
251
Language
English
OCDE Knowledge area
Parasitología
Scopus EID
2-s2.0-85135133570
PubMed ID
Source
Molecular and Biochemical Parasitology
ISSN of the container
01666851
Sponsor(s)
This work was supported by National Council for Science, Technology, and Technological Innovation (CONCYTEC) – World Bank, through its executing unit National Fund for the Development of Science, Technology, and Technological Innovation ( FONDECYT ) contract [ E033-01-08-2018-FONDECYT /Banco Mundial-Programas de Doctorado en Áreas Estratégicas y Generales; Fogarty International Center- National Institutes of Health Training Grant D43 TW001140 . The authors would like to thanks the Dr. Uriel Koziol for his comments and review, and Drs. William Martinez, William Lines, Luis Saavedra, and Jose Calderon for their expertize and support. The Cysticercosis Working Group in Peru: Hector H. Garcia, MD, PhD; Robert H. Gilman, MD, DTMH; Armando E. Gonzalez, DVM, PhD; Manuela Verastegui, PhD; Mirko Zimic, PhD; Javier Bustos, MD, MPH; Seth E. O'Neal, MD, MPH, and Victor C. W. Tsang, PhD (Coordination Board); Silvia Rodriguez, MSc; Isidro Gonzalez, MD; Herbert Saavedra, MD; Sofia Sanchez, MD, MSc, Manuel Martinez, MD (Instituto Nacional de Ciencias Neurologicas, Lima, Peru); Saul Santivanez, MD, PhD; Holger Mayta, PhD; Yesenia Castillo, MSc; Monica Pajuelo, PhD; Gianfranco Arroyo, DVM, MSc; Nancy Chile, MSc; Luz Toribio, Miguel Angel Orrego, MSc (Universidad Peruana Cayetano Heredia, Lima, Peru); Maria T. Lopez, DVM, PhD; Luis Gomez, DVM; Cesar M. Gavidia, DVM, PhD, Ana Vargas-Calla, DVM, Eloy Gonzales, DVM (School of Veterinary Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru); Luz M. Moyano, MD; Ricardo Gamboa, MSc; Claudio Muro; Percy Vichez, MSc (Cysticercosis Elimination Program, Tumbes, Perú); Sukwan Handali, MD; John Noh (Centers for Disease Control, Atlanta, GA); Theodore E. Nash, MD (NIAID, NIH, Bethesda, MD); Jon Friedland (Imperial College, London, United Kingdom).
Sources of information: Directorio de Producción Científica Scopus